Publicaciones en colaboración con investigadores/as de Pierre and Marie Curie University (22)

2024

  1. Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort

    Skeletal Radiology, Vol. 53, Núm. 11, pp. 2409-2416

  2. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

    Seminars in Arthritis and Rheumatism, Vol. 65

  3. Fluctuation of Bone Marrow Lesions and Inflammatory MRI Markers over 2 Years and Concurrent Associations with Quantitative Cartilage Loss

    Cartilage

2023

  1. Exploring the differences between radiographic joint space width and MRI cartilage thickness changes using data from the IMI-APPROACH cohort

    Skeletal Radiology, Vol. 52, Núm. 7, pp. 1339-1348

  2. Machine-learning predicted and actual 2-year structural progression in the IMI-APPROACH cohort

    Quantitative Imaging in Medicine and Surgery, Vol. 13, Núm. 5, pp. 3298-3306

  3. Test–retest precision and longitudinal cartilage thickness loss in the IMI-APPROACH cohort

    Osteoarthritis and Cartilage, Vol. 31, Núm. 2, pp. 238-248

2022

  1. GaitSmart motion analysis compared to commonly used function outcome measures in the IMI-APPROACH knee osteoarthritis cohort

    PLoS ONE, Vol. 17, Núm. 3 March

  2. Osteoarthritis endotype discovery via clustering of biochemical marker data

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 5, pp. 666-675

  3. Pituitary MRI Features in Acromegaly Resulting From Ectopic GHRH Secretion From a Neuroendocrine Tumor: Analysis of 30 Cases

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 8, pp. e3313-e3320

  4. Predicted and actual 2-year structural and pain progression in the IMI-APPROACH knee osteoarthritis cohort

    Rheumatology (Oxford, England), Vol. 62, Núm. 1, pp. 147-157

  5. Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

    Annals of the Rheumatic Diseases

  6. Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohort

    BMC Musculoskeletal Disorders, Vol. 23, Núm. 1

  7. The association of the lipid profile with knee and hand osteoarthritis severity: the IMI-APPROACH cohort

    Osteoarthritis and Cartilage, Vol. 30, Núm. 8, pp. 1062-1069

2021

  1. Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 6, pp. 1311-1319

  2. Neuropathic pain in the IMI-APPROACH knee osteoarthritis cohort: Prevalence and phenotyping

    RMD Open, Vol. 7, Núm. 3

  3. Relationship between motion, using the GaitSmartTM system, and radiographic knee osteoarthritis: an explorative analysis in the IMI-APPROACH cohort

    Rheumatology (Oxford, England), Vol. 60, Núm. 8, pp. 3588-3597

  4. Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

    European Journal of Pain (United Kingdom), Vol. 25, Núm. 7, pp. 1525-1539

2020

  1. Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers

    BMJ open, Vol. 10, Núm. 7, pp. e035101

2019

  1. Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritis

    Arthritis Research and Therapy, Vol. 21, Núm. 1

2017

  1. The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes–associated osteoarthritis

    Journal of Biological Chemistry, Vol. 292, Núm. 35, pp. 14505-14515